Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on EBR Systems.
RELATED STOCKHEAD STORIES
Health & Biotech
Five ASX healthcare companies poised for game-changing catalysts
Health & Biotech
EBR seeks key WiSE US reimbursement
Health & Biotech
Health Check: Thirsty Chimeric goes to the well for funding top-up
Health & Biotech
ASX innovators reshaping traditional medical treatments
News
Closing Bell: Another China boost for mining stocks; Odessa soars 150pc on uranium project backing
Health & Biotech
‘Closer to US commercialisation’ – EBR achieves major FDA milestone
News
Market Highlights: All eyes on another ASX record, and why investors could pile on stocks before year-end
Health & Biotech
Scott Power: Which health ‘underperformer’ just made a big move?
News
Closing Bell: ASX choppy as traders sit it out; BPM soars on Mt Gibson gold find
Health & Biotech
EBR begins $50m capital raise to commercialise WiSE leadless pacemaker
Stockhead TV
Long Shortz with EBR Systems: regulatory submission a major milestone
Health & Biotech
‘Significant milestone’ – EBR submits final PMA module to FDA
Health & Biotech
Curvebeam’s “weight-bearing CT scanner” to gain more traction after FDA clearance
Health & Biotech
ASX medtechs at heart of growing cardiac care market
Investor Guides
Investor Guide: Health & Biotech FY2025 featuring Tim Boreham
Experts
ScoPo’s Powerplays: ASX health stocks rise despite Friday selloff, and what’s this – a potential cure for ageing?
Stockhead TV
